PREJILA BALAKRISHNAN: Open Payments
NPI 1649774852 · BRANDON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,091 in 109 payments from 19 companies in 2025. Trend: 2023 $1,901 · 2024 $2,012 · 2025 $2,091
Food & beverage: $2,074Education: $17
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 37 | $586 |
| AstraZeneca Pharmaceuticals LP | 10 | $197 |
| Insmed, Inc. | 12 | $192 |
| Regeneron Healthcare Solutions, Inc. | 7 | $185 |
| Baxter Healthcare | 5 | $127 |
| United Therapeutics Corporation | 5 | $94 |
| Amgen Inc. | 5 | $91 |
| Grifols USA, LLC | 3 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $82 |
| Verona Pharma, Inc. | 3 | $75 |
Products named: NUCALA, DUPIXENT, Arikayce, Hillrom - Vest System Model 105 Home Care, TEZSPIRE, FASENRA, TRELEGY ELLIPTA, Tyvaso.
Industry payments across FL — which companies pay providers there.
